Navigation Links
Oramed Pharmaceuticals Completes $5.6 Million Funding to Advance Clinical Trials
Date:12/11/2012

utions for drugs and vaccines currently delivered via injection. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at Jerusalem's Hadassah Medical Center. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule (ORMD-0801) currently approaching FDA-approved Phase 2 clinical trials; and with its oral exenatide capsule (ORMD-0901), currently approaching Phase 1b/2a trials, the results of which are expected in Q1 2013. The Company's corporate and R&D headquarters are based in Jerusalem.  

The Company's fact sheet can be viewed here.

For more information, the content of which is not part of this press release, please visit  http://www.oramed.com.

Forward-looking statements: This press release contains forward-looking statements. For example, we are using forward-looking statements when we discuss the projected commencement dates for our upcoming clinical trials, timeline for submission of the IND application, or when results are anticipated. These forward-looking statements are based on the current expectations of the management of Oramed only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval or patent protection for our product candidates; competition from other pharmaceutical or biotechnology companies; and our ability to obtain additional funding required to conduct our research, development and commercialization activities. In addition, the following fact
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012
2. Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand
3. Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
8. Icahn Issues Statement Regarding Amylin Pharmaceuticals
9. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
10. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
11. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 24, 2015 ... addition of the "Global Array Instruments Market ... The global array instruments market to grow at ... 2014-2019 The global array instruments market can ... microarrays, and others including tissue microarrays and cell ...
(Date:6/30/2015)... Pulse Light Clinic in London,s ... part of their ongoing research into the condition. They wanted ... Rosacea. The survey participants were aged between 20 and 60 ... The results revealed some rather surprising statistics: ... to visit their GP for Rosacea treatment. The ...
(Date:6/30/2015)... , June 30, 2015  Inari Medical, Inc. announced ... B venture capital financing. The financing was led by ... Versant Ventures and US Venture Partners.  The round also ... "We are very pleased to complete this financing ... Bill Hoffman , who joined in February 2015 ...
Breaking Medicine Technology:Global Array Instruments Market 2015-2019 - Advances in Personalized Medicines with Affymetrix, Agilent Technologies & Illumina Dominating 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3
... Reportlinker.com announces that a new market ... Infectious Immunology Reagents, ... Analysis, Competitive Landscape and Market Forecasts to ... Infectious Immunology Reagents, Instruments ...
... Reportlinker.com announces that a new market research report is ... - Global Drug Forecasts and Treatment Analysis to 2020 ... Bladder Cancer - Global Drug Forecasts ... Summary GlobalData, the ...
Cached Medicine Technology:Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 2Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 3Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 4Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 5Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 6Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 7Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 8Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 9Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 10Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 11Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 12Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 13Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 14Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 15Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 16Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 17Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 18Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 19Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 20Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 21Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 22Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 23
(Date:6/30/2015)... ... June 30, 2015 , ... New Xarelto lawsuit ... the use of new forms, according to attorneys handling Xarelto lawsuits ... Short Form Complaint, “provide guidance” for plaintiffs’ attorneys in filing new claims, according ...
(Date:6/30/2015)... ... June 30, 2015 , ... Bill Howe Plumbing, Inc. ... San Diego. Bill Howe offers all employees ample opportunity for education and training ... notably through the local Plumbing-Heating-Cooling-Contractors of San Diego (PHCC-SD). The San Diego ...
(Date:6/30/2015)... ... , ... Lecrae is quickly developing into one of the biggest music stories ... York Times to Billboard Magazine and Variety, among others. His transparency and honest ... so many people are taking notice. , “We are very excited about this event! ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... scientists and analysts who are currently attending an accredited American educational institution through ... has provided new insight into healthcare, the environment, political campaigns, and a variety ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Scott Purdy, ... its name to Provider XO. Scott Purdy stated that the XO stands for eXtra ... solutions that automate the workflow processes of the Revenue Cycle. , Provider XO, ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 2Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 3Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 2Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 3Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 2Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 3Health News:Izenda Offers Embedded BI and Analytics Scholarship 2Health News:Izenda Offers Embedded BI and Analytics Scholarship 3Health News:Dephinitive Systems Is Getting a New Name 2
... 5 (HealthDay News) -- Children with HIV who receive ... fat (lipid) levels, and would benefit from guidelines aimed ... The findings are published in JAIDS: Journal of ... the first crucial step in minimizing cardiovascular disease complications ...
... in The Journal of Sexual Medicine reveals ... loss improves erectile function, sexual desire and lowers urinary ... MBBch, MD, FRACP, FRCP, of the University of Adelaide ... 8 weeks. The men received either a meal replacement-based ...
... , This release is available in Spanish ... for determining whether melanoma has spread can be used safely ... area, according to a new study from the University of ... injecting a special dye to identify the first node where ...
... Aug. 5 (HealthDay News) -- Post-traumatic stress disorder was ... after the shooting rampage at the school in April 2007, ... lone gunman, 49 students and faculty members were shot and ... to post-traumatic stress among the students were the death or ...
... , FRIDAY, Aug. 5 (HealthDay News) --,Smokers who ... because the supplement protects them from the harmful affects of ... some people who smoke mistakenly believe the vitamins will reduce ... often. The study noted that such trading of a virtuous ...
... , THURSDAY, Aug. 4 (HealthDay News) -- Compared with high ... likely to smoke only occasionally, or smoke fewer cigarettes each ... that among high school smokers, the percentage of teens considered ... -- dropped from 18 percent in 1991 to about 8 ...
Cached Medicine News:Health News:Children's HIV Drugs May Cause High Cholesterol 2Health News:Sentinel node biopsy safe, effective in head and neck melanomas, U-M study finds 2Health News:Months After Shootings, Many Virginia Tech Students Suffered PTSD 2Health News:Smokers Mistakenly Believe Vitamins Protect Them From Cancer 2Health News:Today's Teens Less Likely to Be Heavy Smokers, Study Finds 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: